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Modeling Neisseria meningitidis metabolism <p>A genome-scale flux model for primary metabolism of <it>Neisseria meningitidis </it>was constructed; a minimal medium for growth  of <it>N. meningitidis </it>was designed using the model and tested successfully in batch and chemostat cultures.</p>
Abstract
Background: Neisseria meningitidis is a human pathogen that can infect diverse sites within the
human host. The major diseases caused by N. meningitidis are responsible for death and disability,
especially in young infants. In general, most of the recent work on N. meningitidis focuses on
potential antigens and their functions, immunogenicity, and pathogenicity mechanisms. Very little
work has been carried out on Neisseria primary metabolism over the past 25 years.
Results: Using the genomic database of N. meningitidis serogroup B together with biochemical and
physiological information in the literature we constructed a genome-scale flux model for the
primary metabolism of N. meningitidis. The validity of a simplified metabolic network derived from
the genome-scale metabolic network was checked using flux-balance analysis in chemostat cultures.
Several useful predictions were obtained from in silico experiments, including substrate preference.
A minimal medium for growth of N. meningitidis was designed and tested succesfully in batch and
chemostat cultures.
Conclusion: The verified metabolic model describes the primary metabolism of N. meningitidis in
a chemostat in steady state. The genome-scale model is valuable because it offers a framework to
study N. meningitidis metabolism as a whole, or certain aspects of it, and it can also be used for the
purpose of vaccine process development (for example, the design of growth media). The flux
distribution of the main metabolic pathways (that is, the pentose phosphate pathway and the
Entner-Douderoff pathway) indicates that the major part of pyruvate (69%) is synthesized through
the ED-cleavage, a finding that is in good agreement with literature.
Background
Neisseria meningitidis is a human pathogen that can infect
diverse sites within the human host. The major diseases
caused by N. meningitidis - meningitis and meningococcal
septicemia - are responsible for death and disability, espe-
cially in young infants. There are different pathogenic N.
meningitidis isolates, of which serogroups B and C cause the
majority of infections in industrialized countries, whereas
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strains of group A and C dominate in less developed countries
[1]. Some disease control has been achieved by vaccination
with polysaccharide vaccines. Effective conjugate vaccines
against group C organisms have been licensed in the United
Kingdom and other countries [2]. At present there is no vac-
cine available against group B organisms, which are the pre-
dominant cause of meningococcal disease in developed
countries [3]. Development of a safe and effective vaccine
based on the serogroup B capsular polysaccharide is compli-
cated because of the existence of identical structures in the
human host [4]. This results in poor immunogenicity and the
risk of inducing autoimmunity [5].
Current strategies for developing a vaccine to prevent disease
caused by serogroup B meningococci include outer mem-
brane protein- and lipopolysaccharide-based approaches [3].
In addition, the systematic search of genomic information,
termed 'reverse vaccinology', has been used to identify novel
protein antigens [6-10]. Genomic-information-based analy-
sis of pathogens has dramatically changed the scope for
developing improved and novel vaccines by increasing the
speed of target identification in comparison with conven-
tional approaches [11].
The outer membrane protein PorA has been identified as a
major inducer of, and target for, serum bactericidal antibod-
ies and is expressed by almost all meningococci, which pin-
points PorA as a promising vaccine candidate [12]. However,
PorA appears to be heterogeneous, which will mean the devel-
opment of a multivalent vaccine in which various porA sub-
types are present in order to induce sufficient protection.
Although various approaches can be used in the development
of a multivalent vaccine, the use of genetically engineered
strains expressing more than one PorA subtype to overcome
the problem of heterogeneity seems promising [13]. At the
Netherlands Vaccine Institute (NVI), a vaccine against sero-
group B meningococci is currently being developed. It is
based on different PorA subtypes contained in outer mem-
brane vesicles (OMVs). An important aspect of this develop-
ment trajectory is the process development of the cultivation
step, which includes, for example, the design of a culture
medium. Genome-scale constraints-based metabolic models
are useful tools for this.
I n  g e n e r a l ,  m o s t  o f  t h e  r e c e n t  w o r k  o n  N. meningitidis,
whether based on genomic information or not, focuses on
potential antigens and their functions, on immunogenicity,
and on pathogenicity mechanisms. Very little work has been
carried out on Neisseria primary metabolism over the past 25
years. However, the information provided by the genome can
also be used to obtain information on the metabolic capabili-
ties of the organism. This is done by screening the genome for
open reading frames (ORFs) that code for enzymes present in
the primary metabolism, yielding a genome-scale metabolic
network. Such a network may still contain gaps due to the
incomplete or incorrect annotation of the genome. Using bio-
chemical literature, transcriptome data or by direct measure-
ments, the presence of missing enzymatic reactions may be
proved and the network can be completed. Often, such a com-
plete model contains underdetermined parts due to the pres-
ence of parallel or cyclic pathways. This means that for certain
parts of the network the flux values cannot be determined. In
order to narrow down the number of possible solutions for
these parts, constraints can be set on certain enzymatic reac-
tions on the basis of biochemical and thermodynamic infor-
mation found in the literature or determined experimentally.
A schematic diagram of how the genome-scale flux model was
constructed and verified using flux balance analysis (FBA) is
shown in Figure 1.
Genome-scale constraints-based metabolic models have been
built for several organisms, as summarized by Palsson and
colleagues [14]. They can be used to analyze culture data, to
get a better understanding of cellular metabolism, to develop
metabolic engineering stategies [15-17], design of media and
processes [17-19] and even for online control of the process
[20]. Knowledge about metabolism, as contained in these
models, is very useful for the development of an efficient cul-
tivation process. Notably, product quality and quantity are
primarily determined in the cultivation process.
The aim of this study was to construct a metabolic model of
serogroup B N. meningitidis (MenB) based on genome anno-
tation and the biochemical literature for effective process
development purposes. The model was verified experimen-
tally using flux-balance analysis (FBA) for steady-state chem-
ostat data.
Results and discussion
Construction of the genome-scale metabolic model
The available genome sequence of MenB [21] and its annota-
tion in the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database [22] was taken as starting point for model
construction. As described by Heinemann and co-workers
[23], the KEGG database was corrected for obvious errors
[24] and complemented using the database of The Institute
for Genome Reearch (TIGR) [25], which is based on the same
sequence data, but runs a different annotation methodology,
and the BioCyc database [26]. These databases, along with
biochemical information found in the literature, provided the
information needed to construct the genome-scale metabolic
model. The genome-scale model was next simplified by lump-
ing successive reactions together and removing dead ends.
This led to the simplified model shown in Figure 2. The com-
plete reaction database along with the genes involved,
enzyme numbers and metabolites is in Additional data file 1.
From this reaction database, parts that describe the main pri-
mary pathways were selected and cross-checked with the
literature.http://genomebiology.com/2007/8/7/R136 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. R136.3
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Glucose metabolism
According to the genomic information for MenB, glucose can
be completely catabolized through the Entner-Douderoff
pathway (ED) and the pentose phosphate pathway (PP). The
Embden-Meyerhof-Parnas glycolytic pathway (EMP) is not
functional, because the gene for phosphofructokinase (EC
2.7.1.11) is not present. Studies on the utilization of glucose in
N. meningitidis [27-33] confirm the presence of enzymes
related to the EMP, ED and PP pathways. However, it was
found that the EMP pathway does not contribute to pyruvate
synthesis, indicating that, in accordance with the missing
phosphofructokinase gene, this pathway is not functional. On
the basis of genomic information, glyceraldehyde phosphate
and fructose-6-phosphate, which are formed in the PP path-
way, can be recycled to glucose-6-phosphate. This indicates
that in theory glucose can be completely oxidized in the PP
Schematic representation of model construction Figure 1
Schematic representation of model construction. The genome can be classified as the first-level database. holding the potential functions of an organism. 
The transcriptome can be classified as the second-level database of functions describing the actual expression of genes, and the proteome can be classified 
as the third-level database of functions describing the actual expressed proteins. The metabolome (and fluxome) can be classified as the fourth-level 
database holding the complete collection of metabolites and reactions in which the metabolites participate. The metabolome, and to a lesser extent the 
proteome, determine the functionality of the cell [146]. In principle, all databases can be used as source of input for construction (or extension) of a 
genome-scale model (white arrows). In our study, information provided by the genome and the literature was used for model construction (black boxes). 
A minimal medium for growth was derived from the genome-scale model (upper gray box). The genome-scale model was simplified as descibed in the text, 
resulting in the 'putative model'. The measured specific metabolic rates and the corresponding measurement variances used in flux balance analysis (FBA) 
were calculated using Monte Carlo Simulation (MCS) with the measured experimental data and their standard deviation as input. The final model, verified 
by FBA, can be used for process development purposes (for example, optimization of growth medium, lower gray box). Subsequently, the model can be 
extended to the desired informative level using all available sources of information (light gray circle).
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pathway to CO2, forming six NADPH. In practice, it was
found that glucose is mainly catabolized by the ED pathway
and to a lesser extent by the PP pathway [32]. On the basis of
14C studies, Jyssum [32] roughly calculated that the ED cleav-
age always synthesizes the major part of pyruvate (67-87 %)
and the PP pathway accounts for the remaining part. Morse
and co-workers [34] found similar results for Neisseria gon-
norhoeae, which is biochemically similar to N. meningitidis
[35].
The tricarboxylic acid cycle
All the genes for the tricarboxylic acid cycle (TCA cycle, citric
acid cycle) enzymes are present in the MenB genome, except
for the gene for malate dehydrogenase. To establish oxidation
of malate to oxaloacetate, the MenB genome suggests the
FAD-dependent malate:quinone oxidoreductase
(NMB2069). Studies of the TCA cycle and related reactions
[35-42] in N. meningitidis and N. gonorrhoeae indeed con-
firm the presence of all citric-acid-cycle enzymes except
malate dehydrogenase. Although activity of the FAD-depend-
ent malate:quinone oxidoreductase has not been measured,
Simplified metabolic model of N. meningitidis Figure 2
Simplified metabolic model of N. meningitidis. As described in the text, the simplified model was obtained by simplification of the genome-scale model. For 
ease of understanding, only the main pathways were admitted into the diagram illustrated here. A complete overview of the model including a list of all 
abbreviations used is in Additional data file 1.
CIT
AKG
SUCCOA
FUM
MAL
ACCOA
OXA
PYR
PEP
CO2
ACE
LIPIDS
GAP
F6P ARG
CARBP
NH3
GLU
NH3
PRO
GLN
ASN
GLC G6P
X5P
E4P
S7P
RU5P
NH3
PRPP
ASP4SA
HSER
DAP
HCYS
OBUT
MET
ACE
H2S
NH3
LYS
AICAR
HIS
IMP
UMP
ILE
CHOR
PRE
ANT
SER
GLY
IVA LAC
LEU VAL
ALA
TRP
PHE
TYR
CYS
H2S
THS
O2
ETH
6PG
HD6PG
UDPNAG
PEPTIDO
LPS
SUC
CO2
CO2 ASP
CO2
TCA cycle
CO2
NH3
R5P
PP
pathway
E
M
P
p
E
D
 
p
a
t
h
w
a
y
CO2
NH3
CO2
CO2 DNA & RNA
CO2
THR
CO2
3PG
AA PROTEIN
MACROMOLECULES BIOMASShttp://genomebiology.com/2007/8/7/R136 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. R136.5
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2007, 8:R136
its presence is plausible as indicated by an operational TCA
cycle. The TCA cycle, ED pathway, PP pathway and the dys-
functional EMP pathway are shown schematically in Figure 2.
Anaplerotic reactions
In the MenB genome, a gene for phosphoenolpyruvate car-
boxylase (NMB2061) is present. Studies on phosphoe-
nolpyruvate carboxylase activity [35,43,44] confirm the
presence of a specific irreversible phosphoenolpyruvate car-
boxylating activity, EC 4.1.1.31. Other phosphoenolpyruvate-
carboxylating enzymes have not been annotated in the MenB
genome. In addition, the gene for malic enzyme, EC 1.1.1.38
(NMB0671), is present in the genome. On the basis of
genomic information, N. meningitidis does not posses a func-
tional glyoxylic acid cycle, as the genes for isocitrate lyase (EC
4.1.3.1) and malate synthase (EC 2.3.3.9) are not present. This
was confirmed by Holten [45] and Leighton [35], who both
did not detect these enzymes in cell-free extracts.
Metabolism of lactate, acetate, glutamate and carbon dioxide
The first work on the growth requirements of Neisseria in a
chemically defined environment was published in 1942 [46]
and provided the basis for many later metabolic studies.
Growth of N. meningitidis requires glucose, pyruvate, or lac-
tate as sole carbon source, and during cultivation on any of
these carbon sources, secretion of acetate into the medium
occurs [47,48]. In addition, a certain environmental CO2 ten-
sion was required to initiate growth [49]. In silico simulation
of biomass growth using the metabolic model showed that
when bacteria are grown on glucose and the oxidation capac-
ity is limiting, acetate secretion occurs. Limitations in oxida-
tion capacity may be due to limitations in metabolism or
limitations in oxygen supply to the culture. In silico simula-
tion of limited oxygen supply was added as an example to
Additional data file 1.
Studies on lactate utilization [50] showed that L-lactate can
be utilized by different meningococcal lactate dehydroge-
nases (LDH). In the MenB genome, an LDH gene (NMB1377)
specific for L-lactate (EC1.1.2.3, EC 1.1.1.27) has been anno-
tated. The predicted amino-acid sequence of this gene, lldA, is
homologous to that of the Escherichia coli lldD gene (43%
similarity) and to other prokaryotic and eukaryotic flavin
mononucleotide-containing enzymes that catalyze the oxida-
tion of L-lactate. However, in E. coli the corresponding lldD
gene is part of an L-lactate-regulated operon also containing
genes for lldP (permease) and lldR (regulatory), whereas the
meningococcal L-LDH gene does not appear to be part of an
operon [50]. A meningococcal lld mutant had reduced L-LDH
activity, but was still able to grow on L-lactate, indicating that
a second L-LDH must exist [50]. At present, no additional
genes have been annotated.
Two LDH genes specific for D-lactate (EC 1.1.1.28) have been
annotated in the MenB genome. These genes, NMB0997 and
NMB1685, are homologous to the E. coli dld and ldhA genes,
respectively (71% and 66% similarity). In agreement with
this, an NAD-dependent D-LDH activity was identified by
Erwin and Gotschlich [51]. ldhA is associated with fermenta-
tive processes [52]. L-lactate is an established and important
intermediate in mammalian metabolism. It is less clear
whether D-lactate also originates from mammalian metabo-
lism. D-lactate can be produced as a byproduct of glucose
metabolism by some lactic acid bacteria as well as by E. coli,
so it may be available on the mucosal surfaces that pathogenic
Neisseria colonize. De Vrese and co-workers [53] showed that
after human consumption of food containing DL-lactic acid
(such as yoghurt), significant levels of both L- and D-lactic
acid were present in the blood. Although both L- and D-lactic
acids were metabolized rapidly, the availability of D-lactate in
humans might explain the presence of specific D-lactate
dehydrogenases in N. meningitidis. Erwin and Gotschlich
[51] showed that N. meningitidis was able to grow on L-lac-
tate at least as well as on glucose, but more recent work of
Leighton [35] contradicts this. He found that growth on L-lac-
tate gave a lower biomass yield and suggested that the addi-
tional ATPs produced during glucose catabolism to pyruvate,
which are not formed when growing on lactate, accounted for
this observation. In addition, the C5 and C6 carbohydrates
required for bioynthesis of macromolecules are synthesized
using the gluconeogenesis pathway when grown on lactate,
which also requires additional ATP. In silico simulation of
biomass growth using the metabolic model confirmed the
observation of Leighton [35] and predicted a 10% higher yield
of biomass on glucose.
According to genomic information, acetate is synthesized via
phosphate acetyltransferase, EC 2.3.1.8 (NMB0631) and ace-
tate kinase, EC 2.7.2.1 (NMB0435, NMB1518) or acetate-CoA
ligase, EC 6.2.1.1 (NMB1555). The presence of phosphate
acetyltransferase and acetate kinase was confirmed by activ-
ity measurements [35]. The hypothesis that acetate is synthe-
sized from pyruvate [38] via cytochrome-linked pyruvate
dehydrogenase (EC 1.2.2.2) might be incorrect, as the
required gene is not annotated. Studies on the catabolism of
pyruvate and acetate [38] showed that acetate can be oxi-
dized, but only when glutamate is present, indicating that
acetate can be oxidized under specific growth conditions.
Because the glyoxylate cycle is not present, C2 compounds
cannot be converted to C4 compounds, which explains the
requirement for glutamate in this case. In silico simulation of
biomass growth using the metabolic model confirmed that
acetate can be oxidized in the presence of glutamate. The
result of this in silico experiment can be found in Additional
data file 1. Ethanol is synthesized from acetaldehyde using
alcohol dehydrogenase, EC 1.1.1.1 (NMB0546). Remarkably,
no gene(s) involved in the biosynthesis of acetaldehyde are
found in the MenB genome. Because ethanol was measured in
the culture supernatant, a biosynthetic pathway to ethanol
must be present. Hence, aldehyde dehydrogenase (EC 1.2.1.3)
was assumed to be present in the metabolic model to com-
plete the biosynthetic pathway to ethanol.R136.6 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. http://genomebiology.com/2007/8/7/R136
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Both Frantz [46] and Grossowics [48] described glutamate as
a requirement in their growth media for meningococci, but
Jyssum [54] showed that ammonium can serve as sole
nitrogen source after meningococcal adaption to glutamate-
free medium. The genes encoding NAD-specific glutamate
dehydrogenase (NMB1476) and NADP-specific glutamate
dehydrogenase (NMB1710) are present in the MenB genome
as well as genes for several aminotransferases. The presence
of NAD-dependent glutamate dehydrogenase was demon-
strated [54] and additional studies of meningococcal
transaminase activity also revealed the presence of transami-
nation to 2-oxoglutarate from a number of amino acid
donors. Holten and Jyssum [55] also found NADP-linked
glutamate dehydrogenase activity. They found that NAD-
linked glutamate dehydrogenase was most active in
glutamate-containing media, whereas the NADP-linked
enzyme dominated in absence of glutamate [55]. They
observed that the NAD-linked enzyme mainly converts gluta-
mate to 2-oxoglutarate and ammonia (catabolism), whereas
the NADP-linked enzyme is responsible for the reverse reac-
tion (anabolism). Because in our study glutamate-free
medium was used, only the NADP-linked glutamate dehydro-
genase was admitted in the metabolic model.
To initiate growth, a certain environmental CO2 tension is
required [49]. This finding is most probably associated with
the high CO2 concentration present in the nasopharynx. In
more recent studies, additional CO2 tension is only used when
bacteria are grown on solid media and is omitted in liquid cul-
tures. It seems plausible that the CO2 tension is only impor-
tant in glutamate-free media, where phosphoenolpyruvate
carboxylase (NMB2061) must be an important link to the cit-
ric acid cycle, whereas this is normally fed by glutamate. This
hypothesis is supported by results obtained by Holten [38]
and in an earlier study by Jyssum and Jyssum [56], who stud-
ied the effect of KHCO3 on endogenous phosphorylation.
Amino-acid metabolism
All genes involved in amino-acid biosynthesis are present in
the MenB genome except the genes coding for alanine
transaminase, alanine dehydrogenase, and phosphoglycerate
dehydrogenase, which is part of the biosynthetic pathway to
serine. For the synthesis of alanine the MenB genome sug-
gests the gene (NMB1823) encoding valine-pyruvate ami-
notransferase (EC 2.6.1.66). To complete the biosynthesis of
serine, phosphoglycerate dehydrogenase was assumed to be
present. In 1989, the physiology and metabolism of N. gonor-
rhoeae and N. meningitidis was reviewed by Chen and co-
workers [57], with emphasis on selected areas that have
implications for pathogenesis. The main focus of this work
was iron metabolism, and amino-acid metabolism was
touched on only briefly for N. gonorrhoeae. Catlin [58] inves-
tigated growth requirements for various Neisseria species,
pointing out the additional need for glutamate, arginine, gly-
cine, serine, and cysteine for some N. meningitidis strains.
However, amino-acid-free growth medium was used earlier
[54], indicating that all biochemical pathways for amino-acid
synthesis in N. meningitidis are available, as supported by the
genomic data. This is confirmed by Leighton [35], who meas-
ured enrichments of all individual amino-acid carbon after
growth on 2-13C- and 3-13C- labeled pyruvate.
Oxidative phosphorylation
MenB genome sequence information indicates the presence
of respiratory complexes I, II and III, suggesting that elec-
trons enter the respiratory chain through NADH dehydroge-
nase (EC 1.6.5.3) or succinate dehydrogenase (EC 1.3.99.1)
and are transferred to the cytochrome bc1 complex through
ubiquinone (EC 1.10.2.2). Oxygen is utilized by cytochrome
cbb3 oxidase (EC 1.9.3.1), which is the only respiratory oxi-
dase encoded by the MenB genome. The cbb3-type oxidases
are usually found in proteobacteria that express these oxi-
dases in response to microaerobic conditions to permit the
colonization of oxygen-limited environments. Thus cbb3-
type oxidases may be an important determinant of patho-
genicity for MenB [59]. N. meningitidis fails to grow under
strictly anaerobic conditions. Under oxygen limitation the
bacterium expresses a denitrification pathway. This reduc-
tion of nitrite to nitric oxide, via nitrite reductase, EC 1.7.2.1
(NMB1623), is regulated by oxygen depletion and nitrite
availability [60,61]. Thus, under microaerobic conditions
nitrite can replace oxygen as an alternative respiratory sub-
strate in N. meningitidis. Because our experiments were not
carried out under microaerobic conditions, nitrite was not
added to the growth medium, and the denitrification pathway
was omitted from the simplified model.
Sulfur metabolism
Frantz [46] and Grossowicz [48] described that reduced sul-
fur in the form of cysteine, cystine, or thiosulfate was required
for growth. Catlin [58] showed that some strains of meningo-
cocci have an absolute requirement for cysteine (or cystine).
Jyssum [54] showed that after adaptation these sulfur
sources could be replaced by sulfate. This was confirmed by
Port and co-workers [62], who showed that numerous sulfur
sources could be used as alternatives to cysteine. DeVoe and
co-workers [63] identified thiosulfate reductase activity in N.
meningitidis serogroup B, but no gene specifically encoding
thiosulfate reductase has been annotated in the MenB
genome. A wide range of sulfur-acquisition routes is available
in  N. meningitidis. Genes encoding sulfate adenylyltrans-
ferase (EC 2.7.7.4), phosphoadenosine phosphosulfate
reductase (EC 1.8.4.8), and sulfite reductase (EC 1.8.1.2) are
present in the MenB genome. On the basis of this informa-
tion, both thiosulfate and sulfate were selected as sulfur
sources in the growth medium for the production of cysteine
and other sulfur-containing compounds.
Cysteine can be converted to the thiol glutathione (GSH) via
glutamate-cysteine ligase, EC 6.3.2.2 (NMB1037), and glu-
tathione synthetase, EC 6.3.2.3 (NMB1559). In turn, GSH can
be converted to cysteine via gamma-glutamyltranspeptidase,http://genomebiology.com/2007/8/7/R136 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. R136.7
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EC 2.3.2.2 (NMB1057), and aminopeptidase N, EC 3.4.11.2
(NMB1416), yielding a functional γ-glutamyl cycle (Figure 3).
This cycle helps to maintain the redox balance [64]. GSH can
be oxidized to glutathione disulfide (GSSG) by glutathione
peroxidase, EC 1.11.1.9 (NMB1621), thereby controlling the
cellular hydrogen peroxide level [65].
In solution, cysteine can be converted chemically to cystine.
Yu and DeVoe [66,67] corrected for this so-called auto-oxida-
tion and suggested that electrons from cysteine enter the elec-
tron-transport chain at the flavoprotein level in a manner
similar to those from succinate and NADH. They even sug-
gested the presence of a specific cysteine oxidase, but no gene
encoding this enzyme has been annotated in the MenB
genome and no additional evidence supporting this
hypothesis was found in the literature. It seems plausible that
cysteine can increase the protonmotive force to drive oxida-
tive phosphorylation. During oxidation of cysteine to cystine,
electrons from cysteine are transferred to oxygen, yielding
reactive oxygen, O2 
-, as shown in Figure 3. This reactive oxy-
gen can reduce cytochrome c, which in turn can provide a
source of electrons for cytochrome cbb3, which reduces oxy-
gen to water, causing the concomitant generation of a proton-
motive force, ΔμH+, and ATP [68]. In addition, cysteine might
be used directly as an electron donor by cytochrome cbb3 but
no evidence supporting this hypothesis was found in the
literature.
Oxidative stress
The reactive oxygen can also be processed by superoxide dis-
mutases - SodC present in the periplasm or SodB present in
the cytosol, EC 1.15.1.11 (NMB0884, NMB1398, respectively),
followed by catalase, EC 6.3.5.5 (NMB1849, NMB1855), to
regenerate oxygen, or by glutathione peroxidase as described
above (see Figure 3). This protection mechanism against oxi-
dative stress has been studied extensively [65]. Seib and co-
workers concluded that N. meningitidis SodB plays a key role
in protection against oxidative killing. The sodC mutant of N.
meningitidis used in their study was no more sensitive to oxi-
dative killing than the wild type. Paradoxically, Wilks and co-
workers [69] found that a sodC mutant is significantly less
virulent, indicating that SodC contributes to the virulence of
N. meningitidis, most probably by reducing the effectiveness
of toxic oxygen host defenses. This was confirmed by Dunn
and co-workers [70], who showed that SodC contributes to
the protection of serogroup B N. meningitidis from phagocy-
tosis by human monocytes/macrophages, with sodC mutant
organisms being endocytosed in significantly higher numbers
than wild-type organisms. In vitro, oxidative stress might be
induced by a high dissolved oxygen concentration, possibly
resulting in oxidative killing. Therefore, the dissolved oxygen
concentration in the chemostat experiments was controlled at
a low level of 30%.
Metabolism of macromolecules
The metabolism of pyrimidine bases and nucleosides in N.
meningitidis has been reviewed and studied extensively [71].
Although some of the early work contradicts the current
information from the MenB genome in terms of pathway
description, the results indicate that the required routes for
pyrimidine biosynthesis are available in the genome. Further-
more, the MenB genome contains all the genes encoding the
enzymes for the biosynthesis of UMP. Activities of the
enzymes for this biosynthetic pathway were found previously
in cell-free extracts [72].
In Gram-negative bacteria, such as N. meningitidis and E.
coli, the cell envelope consists of an outer membrane, a dense
peptidoglycan layer, and a cytoplasmic or inner membrane.
The outer membrane has an asymmetrical organization in
which the outside layer is primarily composed of lipopolysac-
charide (LPS) and proteins and the inside layer contains
phospholipids [73]. The inner membrane has a symmetrical
phospholipid bilayer stucture, holding proteins primarily
responsible for regulating the flow of nutrients and metabolic
products in and out of the bacterium [74].
Membrane phospholipids form a major constituent of the cell
envelope of N. meningitidis and maintain the integrity of the
outer membrane. Rahman and co-workers [75] summarized
Oxidation of cysteine to cystine Figure 3
Oxidation of cysteine to cystine. Cysteine (CYS) is oxidized to cystine 
(CYST), forming reactive oxygen O2
- (step 1), which can reduce 
cytochrome c (step 4). The electron is used by cytochrome cbb3, which 
reduces oxygen to water and causes the concomitant generation of a 
protonmotive force, ΔμH+ (step 5). The protonmotive force is in turn used 
to form ATP (step 6). Step 2 involves the formation of hydrogen peroxide 
(H2O2) from O2
- by superoxide dismutase followed by catalase to 
regenerate oxygen (step 3). Cysteine can be converted to glutathione 
(GSH), via glutamate-cysteine ligase and glutathione synthetase (step 8). In 
turn, GSH can be converted to cysteine via gamma-glutamyltranspeptidase 
and aminopeptidase N (step 9), yielding a functional γ-glutamyl cycle. GSH 
can be oxidized to glutathione disulfide (GSSG), by glutathione peroxidase 
(step 7).
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early studies conducted in the 1960s and 1970s that indicated
that the major phospholipid component of membranes iso-
lated from N. gonorrhoeae consisted largely of phosphati-
dylethanolamine (PE), with varying amounts of
phosphatidylglycerol (PG), cardiolipin (CL), and lysophos-
phatidylethanolamine (LPE). Subsequently, the total cellular
fatty acids and extractable cellular lipids of N. meningitidis
isolates were found to be similar to those of gonococci. The
precise structures of N. meningitidis phospholipids, includ-
ing their fatty-acylation patterns, have been elucidated quite
recently [75]. Interestingly, the latter study shows that a
major fraction (about 11%) of the total phospholipids appears
to be phosphatidate (PA).
Lipid biosynthesis can be divided into two parts: biosynthesis
of the fatty acids that are responsible for the characteristic
hydrophobicity of lipids and attachment of the completed
fatty acids to sn-glycerol-3-phosphate (GL3P), followed by
the addition and modification of the polar head groups to
yield phospholipids [76].
The fatty-acid biosynthetic pathway in N. meningitidis is sim-
ilar to that in E. coli. All genes, except for a homolog of the E.
coli  β-hydroxyacyl-acyl carrier protein (ACP) dehydrase
FabA, are present in the MenB genome. The absence of a fabA
homolog in the MenB genome is not unique, as summarized
by Rahman and co-workers [75], who state that the produc-
tion of unsaturated fatty acids in N. meningitidis and other
species may proceed via different biochemical pathways to
that of E. coli. Homologs to glycerol-3-phosphate acyltrans-
ferase (PlsB) and cardiolipin synthase (YbhO) from E. coli
were not found in the MenB genome. The reported phosphol-
ipid compositions in Neisseria species [75,77-79] in which no,
or only trace quantities of, CL were found can be explained by
the absence of a homolog for ybhO, but the absence of a
homolog for plsB is striking. Apparently the gene(s) encoding
the enzyme responsible for the formation of 1-acyl-sn-glyc-
erol-3-phosphate has not been found in N. meningitidis. In
fact, only 38 of the 125 prokaryotic genomes reported [22]
annotated plsB or plsB homologs, all classified as gamma pro-
teobacteria. Although it is possible that the reaction proceeds
via a different biochemical pathway from that in E. coli, it is
incorporated in the present metabolic model to complete the
biosynthetic pathway to phospholipids.
The overall phospholipid composition used in our study was
based on the information provided by Rahman and co-work-
ers [75] - 11% PA, 71% PE, and 18% PG. In their study, no evi-
dence supporting the presence of LPE was found. Bos and co-
workers [80] reported a neisserial gene pldA (NMB0464),
encoding a phospholipase, and characterized it as a neisserial
autolysin that acts after bacteria have stopped dividing. This
is consistent with LPE only being measurable when cells are
harvested in the late exponential growth phase or stationary
growth phase.
LPS, a second major constituent of the cell-envelope of N.
meningitidis, is often referred to as endotoxin and plays an
important role in virulence. It is held responsible for the
severe pathological effects that occur during invasive menin-
gococcal disease [81]. LPS consists of three parts: a lipid A
part containing unique hydroxy fatty-acid chains, a core oli-
gosaccharide containing 3-deoxy-D-manno-octulosonate
(KDO) and heptoses, and a highly variable sugar backbone. In
E. coli, lipid A is essential for cell viability [82,83], whereas an
LPS-deficient meningococcal strain remains viable [84]. All
genes involved in the biosynthesis of the lipid A of LPS are
present in the MenB genome. Unlike the LpxA acyltranferase,
present in the biosynthetic pathway of E. coli, the MenB LpxA
acyltranferase (NMB0178) favors the substrate 3-OH C12
acyl-ACP [85], yielding a lipopolysaccharide structure as
described earlier [86]. The HB-1 strain used in this study
lacks expression of galE as a result of the deletion made into
the capsule (cps) locus [87], leading to the synthesis of galac-
tose-deficient LPS [88].
Heterogeneity in the LPS sugar backbone can be caused by
phase variation of the genes involved [89], but phase-variable
genes have not been found in the lipid A biosynthetic path-
way. Kulshin and co-workers [90] found minor fractions of
penta- and tetra-acylated lipid A structures in N. meningi-
tidis, but the hexa-acylated structure predominated. Hetero-
geneity in lipid A has been found before in other species.
Rebeil and co-workers [91] found that a shift in growth tem-
perature of the genus Yersinia  induced changes in the
number and type of acyl groups on lipid A, suggesting that the
production of a less immunostimulatory form of LPS upon
entry into the mammalian host is a conserved pathogenesis
mechanism and that species-specific lipid A forms may be
important for life cycle and pathogenicity differences. Other
bacterial species, such as Salmonella typhimurium and Pseu-
domonas aeruginosa, are able to covalently modify their lipid
A through the enzymes PagL and PagP [92,93], but homologs
t o  P a g P  a n d  P a g L  h a v e  n o t  b e e n  f o u n d  i n  m e n i n g o c o c c a l
genomes [94]. Structural analysis by mass spectroscopy of
lipid A from strain HB-1 (data not shown) revealed that a
monophosphorylated form of the above described hexa-
acylated lipid A was present.
The capsular polysaccaride (whose synthesis is directed by
the cps locus) is an important virulence factor in meningococ-
cal pathogenesis and contributes to the survival of N. menin-
gitidis  in the blood stream [95,96]. The biosynthesis of
capsular polysaccharide in N. meningitidis was first
described by Blacklow and Warren [97]. They found that,
unlike in mammalian cells, in Neisseria N-acetylneuraminic
acid (Neu5Ac) is synthesized from N-acetylmannosamine
(ManNAc) and phospoenolpyruvate without phosphorylated
intermediates. Neu5Ac is the most common form of sialic
acid in humans and plays an important role in intercellular
and/or intermolecular recognition [98], explaining the diffi-
culty of developing a safe and effective polysaccharide-basedhttp://genomebiology.com/2007/8/7/R136 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. R136.9
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vaccine. Gotschlich and co-workers [99] determined the com-
position and structure of meningococcal group B capsular
polysaccharide and found that it is composed of α-2,8-poly-
sialic acid polymer chains, which are integrated in the outer
membrane by a phospholipid anchor that is attached to the
reducing end of the carbohydrate chain. This phospholipid
anchor may help stabilize the outer membrane of the menin-
gococcal mutant without endotoxin [84]. As mentioned
above, the strain used in our study lacks the cps locus, as con-
firmed by Bos and Tommassen [100]. We therefore removed
genes involved in sialic acid biosynthesis and polysaccharide
transport from our model, as well as the galE gene. Subse-
quently, the rfbB, rfbA and rfbC genes located downstream of
galE, which code for enzymes involved in the biosynthesis of
dTDP-rhamnose, were also removed, yielding a dysfunctional
biosynthetic pathway. Hence, these pathways were not
included in the simplified model.
Peptidoglycan forms the third major constituent of the cell
envelope of N. meningitidis. Antignac and co-workers [101]
determined the biochemical structure of peptidoglycan in
various N. meningitidis strains in detail and found that it con-
sists of a maximum of two layers. Variations in the degree of
cross-linking and O-acetylation appeared to be associated
with the genetic background of the strains. The percentage of
crosslinking of the peptidoglycan was around 40%, which is
consistent with that determined for other Gram-negative bac-
teria [102-105], whereas the percentage of O-acetylation per
disaccharide was on average 36%. O-acetylation of peptidog-
lycan results in resistance to lysozyme and to other murami-
dases [106], suggesting that nonspecific lysis of the bacteria in
the host enviroment by lysozyme can be prevented. Other
studies show that peptidoglycan structures are recognized by
the innate immune system [107,108]. Consequently, O-
acetylation might contribute to affect the proper response to
infection. Most of the strains analysed by Antignac and co-
workers [101] predominantly contained muropeptides carry-
ing a tetrapeptide chain, but di-, tri- and pentapeptide chains
were also found. Their analysis also showed that none of the
muropeptides carried glycine residues on the peptide back-
bone, as has been observed in gonococci [109,110]. Hence,
meningococci only synthesize D-alanyl-meso-deami-
nopimelate cross-bridges. However, the gene involved in ala-
nyl-meso-deaminopimelate cross-bridging for biosynthesis
of the peptidoglycan polymer structure has not been anno-
tated. The enzyme involved in glycine cross-bridging of pep-
tidoglycan (EC 2.3.2.10) is not present in the MenB genome,
thus confirming the observations of Antignac and co-workers
[101]. The biosynthetic pathway for peptidoglycan biosynthe-
sis in our metabolic model includes the information provided
by Antignac and co-workers [101], using 36% O-acetylation
per disacharride and 40% crosslinking, whereas the model
muropeptide only contains the predominant tetrapeptide
backbone.
Main characteristics of the genome-scale model
The main characteristics of the genome-scale metabolic net-
work are summarized in Table 1. The MenB genome contains
2,226 ORFs of which 2,155 are protein encoding genes, 59 are
tRNA encoding genes and 12 are rRNA encoding genes [111].
At present, 1,307 genes from the total of 2,155 protein-coding
genes have an annotated function (60.6%), of which 146
genes encode transporter functions [112].
For construction of the genome-scale model, a total of 555
ORFs were considered, corresponding to at least 496 associ-
ated reactions (including membrane-transport reactions)
and at least 471 unique metabolites. The exact number of
metabolites cannot be determined accurately because of the
presence of polymerization reactions in which numerous
intermediate compounds can be synthesized. In cases where
numerous ORFs accounted for a single reaction for example,
the various subunits of ATPase) the reaction was counted
once, which explains the lower reaction count compared to
other genome-scale networks [14]. To complete the metabolic
network, two chemical oxidation reactions were added based
on the literature, four reactions were added to account for
biosynthesis of the macromolecules DNA, RNA, protein and
lipid, one reaction was added for biomass assembly and 38
reactions were added to fill pathway gaps (unannotated func-
tions in Table 1). For these unannotated functions, a corre-
sponding gene has not been found in N. meningitidis.
Furthermore, for nine of these functions a corresponding
gene has never been found in any organism. The complete
reaction database along with the genes involved, enzyme
numbers and metabolites can be consulted in Additional data
file 1. A detailed description of the biomass composition and
its biosynthesis is in Additional data file 2.
Table 1
Main characteristics of the genome-scale metabolic network of N. 
meningitidis
ORFs 555
Annotated functions 509
Annotated putative functions 46
Unannotated functions 38
Metabolites
Unique intracellular metabolites 471
Extracellular metabolites (minimum, based on measurements) 33
Reactions 496
Intracellular reactions 451
Transport fluxes 74
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Construction of a simplified metabolic model
The genome-scale model was simplified to the model shown
in Figure 2. Simplification was carried out purely for ease of
understanding and was done as follows. First, successive
reactions in a linear pathway were lumped up to the first
branch point. Second, some reactions were neglected (for
example, biosynthesis of amines, cofactors and vitamins)
because the production rate of these metabolites is very small
in comparison with the production rate of macromolecules
required for biomass assembly. Third, reactions were omitted
to prevent 'dead ends'. A dead end exists in a metabolic net-
work if a metabolite is at the end of a metabolic pathway and,
based on the literature and our own measurements, the
metabolite does not accumulate in biomass nor is it excreted
to or taken up from the medium. Examples in our case are
hydroxypyruvate and lactaldehyde. In reactions that can use
NADH or NADPH as co-factors, the NADH co-factor was
used in the model unless stated otherwise in Additional data
file 1. In the approach used, a distinction between NADH and
NADPH preference cannot be made. Additional enzymatic
analysis to distinguish between NADH or NADPH preference
is complicated because of the presence of transhydrogenase.
The final simplified model used for flux-balance analysis
included 161 reactions (129 intracellular reactions, 33 trans-
port fluxes) and 131 intracellular metabolites and can be con-
sulted in Additional data file 1.
Modeling of the metabolic network
In metabolism, substrates are converted into the different
macromolecules that together make up biomass. Thus, the
macromolecular composition of biomass determines the flux
distribution, and a shift in the macromolecular composition
of biomass will result in a shift in the flux distribution. Conse-
quently, experimental determination of the biomass compo-
sition is very important in mathematical modeling of cellular
metabolism, as described in detail elsewhere [113,114]. The
measured concentrations of substrates, biomass and prod-
ucts, which can be found in Additional data file 2, were con-
verted to measured conversion rates using mass balances.
Monte Carlo simulation
Before error diagnosis was performed, errors in the primary
measurements were translated to errors in measured conver-
sion rates using a Monte Carlo approach [115,116]. In complex
mass balance equations (for example, CO2 production rate) in
which various measured values with various standard devia-
tions are included, determination of the total variance is quite
laborious using standard error propagation. Therefore, vari-
ances of the measured conversion rates of the various sub-
strates and products were calculated using Monte Carlo
simulation. The exact procedure involved mass balances that
were formulated for the reactor configuration and is
described in detail in Materials and methods. Accurate results
were obtained after 10,000 simulations, as shown in Figure 4.
The resulting average measured conversion rates and their
corresponding variances were then used as input for flux-bal-
ance analysis. In addition (data not shown), all separate sim-
ulated measured conversion rates were also used directly as
input for flux-balance analysis, resulting in 10,000 flux distri-
butions. The final average flux distribution, calculated from
these 10,000 distributions, was identical to the one obtained
using the average measured conversion rates as input. All cal-
culated conversion rates as well as the fluxes appeared to be
normally distibuted.
Error diagnosis and balancing
Laws of conservation result in a number of linear constraints
on the measured conversion rates of the various compounds.
The measured conversion rates and their corresponding var-
iances, which were calculated using Monte Carlo simulation,
were subjected to gross error diagnosis. First the redundancy
matrix,  R, was calculated as described previously [117].
Matrix R, expressing the conservation relations between the
measured conversion rates only, contained two independent
equations. Inspection of these equations indicated a carbon
and a nitrogen balance. The residuals obtained after multipli-
cation of the redundancy matrix with the measured
conversion rates could be explained on the basis of random
measurement variances [118] with test values of he = 1.598
and he = 1.391 for the first and second experimental set of
measured rates, respectively, where the 95% chi-square criti-
cal value is 5.992. Also, the individual carbon and nitrogen
balance could be closed for both datasets. Thus, the measure-
ments contained no gross errors and the model is also valid
with respect to the measurements. The results of the statisti-
cal test are shown in Additional data file 1. Hence, the meas-
ured rates were balanced by minimizing the square of the
Determination of measurement variance using Monte Carlo simulation Figure 4
Determination of measurement variance using Monte Carlo simulation. 
When an arbitraty value (r) for the production rate of a hypothetical 
product of 1.00 with standard deviation of 0.01 was used as input for 
Monte Carlo simulation, 104 simulations were required to obtain the 
original input value (1.00 ± 0.01), showing that accurate results for the 
actual measured input values can be expected after 104 simulations.
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distance between the actual measurement and the adjusted
measurement with the measurement variance as a weighing
factor as described previously [117]. The resulting balanced
measurement rate vector, which is more accurate than the
primary measurement rate vector, was used to calculate the
unknown fluxes and conversion rates (see Additional data file
1). The combinations of fluxes and unknown exchange rates
that cannot be uniquely identified (that is, calculated from the
measurements) were isolated using singular value decompo-
sition. These underdetermined parts of the simplified net-
work are listed in Additional data file 1.
Flux distribution
As stated, the network contains underdetermined parts, for
which the flux values cannot be calculated from the measured
rates. To calculate a solution for these fluxes, constraints can
be set on certain enzymatic reactions on the basis of available
biochemical and thermodynamic literature. In addition,
objective functions and linear optimization can be used to cal-
culate fluxes and unknown rates in the underdetermined
part(s) of the network, as explained in Materials and meth-
ods. The main objection to the technique of linear program-
ming to find a solution for an underdetermined part of the
network is that the objective function may not be valid for the
biological system. The minimum norm constraint is an opti-
mization function that minimizes the length of the solution
vector without any further restrictions, as explained in more
detail in Materials and methods, and was used to calculate
fluxes and unknown rates in the underdetermined part(s) of
the network. Like Bonarius [119], we hypothesize that the
minimum-norm constraint correctly assumes that the total
flux activity is minimized in order to fulfil the efforts of the
bacteria to attain an efficient flux distribution.
The flux values are given in Additional data file 1. For most of
the underdetermined fluxes realistic values are obtained
using the minimum norm solution. For instance, the
calculated flux ratio between the ED cleavage and the PP
pathway shows that the major part of pyruvate (69 ± 6%) is
synthesized through the ED cleavage, which is in agreement
with the literature [32]. Furthermore, we calculated that 91 ±
7% of the NADPH that is produced in both the PP-pathway
(flux 17 and 18) and the TCA cycle (flux 2) is used for biosyn-
thesis while 9 ± 7 % is converted to NADH using transhydro-
genase (flux 74). Some of the flux values obtained for
underdetermined fluxes using the minimum-norm constraint
are unlikely, and are clearly an artifact of the minimum-norm
solution. These are the positive sulfate production rate and
the negative flux from pyrophosphate to phosphate (flux 71).
By measuring thiosulfate, sulfate, and H2S, these underdeter-
mined fluxes become determined and this problem can be
solved. It must be emphasized that the actual flux distribution
through the underdetermined parts may very well be differ-
ent from the minimum-norm solution. Only isotopic tracer
experiments can deliver true flux values for some underdeter-
mined parts, like, for example, the ED and PP pathway. Nev-
ertheless, the calculated flux distribution in the present study
also shows that it is in agreement with the literature for spe-
cific underdetermined parts of the network.
Application of the model for process development 
purposes
The metabolic model presented in this paper offers a frame-
work to study N. meningitidis metabolism as a whole or cer-
tain aspects of it. For example, gene deletion analysis could be
carried out to study which genes are essential for growth in
the host environment, which in turn could serve to identify
possible targets for new antibiotics. In the present study,
apart from the data analysis discussed above, the model was
developed for process development purposes. In particular,
the model was used for the design of minimal medium for
growth of N. meningitidis.
Design of minimal medium
The amount of available literature describing the require-
ments for growth of N. meningitidis is tremendous, which
provided an easy starting point for designing a minimal
growth medium. The MenB genome was next checked for the
presence of the membrane-transport functions that are
required for utilization of substrates. In the case of carbon,
nitrogen, and sulfur substrates the genome was also checked
for the presence of subsequent processing pathways.
The membrane-transport functions for utilization of the inor-
ganic ions Na+, K+, Mg2+, Cl-, and PO4 
3 are annotated in the
MenB genome. Genes for membrane transport of the trace
elements Fe3+, Cu2+, Zn2+, Co2+, Ca2+, and Mn2+ are also
annotated. These ions often function as cofactors for metal-
activated enzymes or metalloenzymes. For instance, copper-
zinc superoxide dismutase is a metalloenzyme that uses cop-
per and zinc to help catalyze the conversion of superoxide
anion to molecular oxygen and hydrogen peroxide. Further-
more, aconitase (a TCA enzyme) contains several iron atoms
bound in the form of iron-sulfur clusters, which participate
directly in the isomerization of citrate to isocitrate. The only
trace element added as a supplement to the medium that
could not be related to an annotated function in the genome
was molybdenum. In general, molybdenum is necessary for
the activity of several enzymes [120] and is added as trace
element in media for growth of various bacteria, such as E.
coli [121]. For this reason MoO4 
2- was added to complement
the minimal medium. However, it remains unclear whether
molybdenum is an essential requirement for growth of N.
meningitidis.
N. meningitidis is able to metabolize a variety of sugars and
amino acids for biosynthesis of macromolecules and their
precursors as indicated by the presence of the relevant trans-
porter genes and the available processing pathways (ED path-
way, PP pathway, amino-acid biosynthesis). The main
utilizable carbon sources include glucose, sucrose, lactose,
fructose, maltose, gluconate, lactate, and pyruvate. An aminoR136.12 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. http://genomebiology.com/2007/8/7/R136
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acid like glutamate can serve as both a carbon and a nitrogen
source, as the glutamate deamination product (α-ketoglutar-
ate) can be metabolized via the citric acid cycle. However, in
the literature no media were found in which glutamate was
used as the sole carbon and nitrogen source for growth of N.
meningitidis. A possible disadvantage of using other amino
acids as carbon and/or nitrogen sources is that the deamina-
tion might result in acid products that cannot be processed
metabolically and will therefore accumulate. To select the
best carbon source, the metabolic model was used to simulate
growth on different carbon sources in silico. In all in silico
experiments, ammonium was selected as the sole nitrogen
source based on the presence of the ammonium transporter
Amtb (NMB0615) and the NADP-specific glutamate dehydro-
genase processing pathway (NMB1710).
For the in silico simulations, the uptake of the carbon source
was fixed at a certain value and biomass formation was opti-
mized. Furthermore a maintenance requirement of 2.81 × 10-
3 mol/gram/hour was set, which was obtained from the liter-
ature [122]. The predicted yields of biomass on various car-
bon substrates are given in Table 2. The metabolic model
predicted that glucose is the preferred carbon substrate for
growth of N. meningitidis in terms of biomass yield. Accord-
ingly, glucose was selected as sole carbon source for growth.
When growth was simulated using glucose as the carbon
source, the predicted C:N consumption ratio was 9:1, indicat-
ing the minimal amount of ammonium that is required in the
growth medium. A wide range of sulfur-acquisition routes is
available in N. meningitidis. Both thiosulfate [63] and sulfate
[54] were selected as sulfur sources in the growth medium. In
silico predictions showed that thiosulfate is the preferred sul-
fur source for growth, which can be explained by the fact that
less energy is required for utilization of thiosulfate in compar-
ison with sulfate. The results of these in silico experiments are
listed in Additional data file 1.
Constraint-based models give information on which sub-
strates to use and, for some substrates, in which ratio they
should be used. However, they give no information on the
actual concentrations that should be used. For our study the
required concentrations (by order of magnitude) of the vari-
ous compounds in the minimal medium were derived from
the relevant literature referred to earlier. The resulting mini-
mal medium (see Table 3) is suitable for growth of N. menin-
gitidis (Figure 5). To obtain higher biomass concentrations at
the end of a batch culture further optimization of the concen-
trations is needed.
Conclusion
In silico genome-scale flux models have been proved to give
insight into the complexity of metabolism and can be used
succesfully as tools for medium design and metabolic engi-
neering strategies. Many studies lack sufficient experimental
datasets to check the consistency of the measurements and
the validity of the metabolic network model. In the present
study, the experimental datasets used in flux-balance analysis
proved sufficient to check for the presence of gross measure-
ment errors or errors in the model, neither of which was
found to be present.
Working from the genomic database of MenB together with
biochemical and physiological information provided in the
literature, a genome-scale flux model for vaccine process
development purposes was constructed. From these informa-
tion sources a minimal medium for growth was designed and
Table 2
In silico yield, Yxs of biomass on substrate for growth on different carbon sources
Substrate Yxs in silico (grams per mole carbon (Cmol))
Glucose (GLC) 10.7
Lactate (LAC) 9.6
Glutamate (GLU) 8.2
Acetate (ACE) 0.0 (not possible)
GLC + LAC (50/50 Cmol/Cmol) 10.4
GLC + GLU (50/50 Cmol/Cmol) 9.7
LAC + GLU (50/50 Cmol/Cmol) 9.0
ACE + GLU (50/50 Cmol/Cmol) 6.3
Table 3
Medium composition
Component Concentration
NH4Cl 23.5
NaCl 102
MgSO4.7H2O 2.43
K2HPO4 12.5
KH2PO4 4.58
FeCl3.6H2O 0.30
Trace-element solution (ml/l) 2.0
D-Glucose monohydrate 31.1
Na2S2O3.5H2O 0.38
All values in mM unless stated otherwise.http://genomebiology.com/2007/8/7/R136 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. R136.13
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tested succesfully in batch and chemostat cultures. The sim-
plified metabolic network that was derived from the genome-
scale metabolic network was verified using flux-balance anal-
ysis in two duplo chemostat cultures. The specific rates, being
the input of the model, were generated from the measured
concentrations using Monte Carlo simulation. The model
contains underdetermined parts, for which fluxes were calcu-
lated using the minimum-norm constraint, providing a possi-
ble solution for these underdetermined parts. Despite the
unlikely positive sulfate production rate and the negative flux
from pyrophosphate to phosphate, which are both
underdetermined parts of the network, the flux distribution
for the remaining underdetermined parts seems plausible.
This is strengtened by the observation that the major part of
pyruvate (69 ± 6%) is synthesized through the ED cleavage,
which is in good agreement with the literature [32].
Methods for integration of metabolic network information
with gene-expression profiles (transcriptomics) were
described recently [123-125]. Such studies bridge the gap
between the putative, homology-based information provided
by genomes and the actual situation, and greatly contribute to
further improving our understanding of cellular processes
and function.
Materials and methods
Strain
N. meningitidis strain HB-1, a non-encapsulated, non-pili-
ated variant of the group B isolate H44/76 [100], was used
throughout this study. Stock cultures of strain HB-1 were
stored at -135°C and when required, a 500-ml shake flask,
containing 150 ml of the chemically defined medium
described below, was inoculated. After approximately 8 h of
incubation at 35°C with shaking at 200 rpm in an aerobic
humid atmosphere, the culture was used to inoculate the
medium in the bioreactor.
Medium
The composition of the chemically defined medium described
in this study is based on the information provided by the
genome and the literature as descibed in the text. The compo-
sition of the minimal medium is given in Table 3. The trace-
element solution contained (values in mM) CaCl2.2H2O, 68;
ZnSO4.7H2O, 0.17; Na2MoO4.2H2O, 0.08; MnCl2.4H2O, 0.4;
CoCl2.6H2O, 0.04 and CuSO4.5H2O, 0.04. The medium was
sterilized by filtration (0.22 μm pore size). To prevent precip-
itation, the minimal medium and a sterile solution containing
FeCl3.6H2O in 0.6 M HCl were added separately to the reactor
using two pumps (Watson-Marlow Bredel, Falmouth, UK).
Chemostat cultures
Bacteria were grown in a 3-l autoclavable ADI bioreactor
(Applikon, Schiedam, The Netherlands), operated in chemo-
stat mode, with a working volume of 1.4 l. Temperature, pH,
dissolved oxygen (DO) concentration, and stirrer speed were
contolled at 37°C, 7.0, 30%, and 600 rpm, respectively. The
total gas flow rate was kept constant at 1.0 l/min. The oxygen
concentration was controlled by changing the oxygen fraction
in the gas flow using headspace aeration only. The growth
rate was controlled at 0.04/h. After at least three residence
times, physiological steady state was assumed based on
online measurements (constant DO signal, O2 and CO2 con-
centration in the off-gas) and offline measurements (constant
optical density, zero glucose concentration). In steady state, a
1.0-l sample was taken and divided into portions. After cen-
trifugation of the portions (3000 g, 1 h at 4°C) cells were
washed once with saline solution (0.85 w/v % NaCl) and cen-
trifuged again. After centrifugation, the saline solution was
discarded and the pellet was freeze-dried without additives
(Leybold, Cologne, Germany). The freeze-dried pellet was
stored at -80°C until further analysis. The chemostat cultures
were perfomed in duplicate.
Analytical procedures
Biomass concentration
Dry biomass concentration was determined in fourfold for
each sample by centrifugation (8000 g) of 50.0 ml of culture
broth in preweighed tubes. The cell material was dried at
80°C for at least 24 h. Before weighing, the tubes were cooled
in a desiccator for at least 1 h. Dry cell weight was corrected
for salts present in the medium.
Off-gas analysis
The oxygen and carbon dioxide concentrations in the exhaust
gas from the chemostat cultures were measured with a mass
Growth of N. meningitidis in a minimal medium designed from the model Figure 5
Growth of N. meningitidis in a minimal medium designed from the model. 
Growth of N. meningitidis strain HB-1 in minimal medium in a bioreactor 
operated in chemostat mode after an initial batch phase of approximately 
36 h were assessed by optical density. Two experiments in identical 
medium and growth conditions are shown here. Conditions were as 
described in Materials and methods.
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spectrometer (Prima White Box 600, Thermo Electron,
Winsford, UK).
kLa determination
The volumetric oxygen transfer coefficient, kLa, in the biore-
actor was determined accurately at 37°C using a steady-state
setup and a phosphate-buffered saline solution (NVI, Z3000)
as reference liquid. The steady-state determination method
makes use of the global balance of oxygen over the bioreactor
in the gas phase and liquid phase. The calculated values were
confirmed using the dynamic method with correction of elec-
trode response time [126].
Metabolite concentrations
Glucose and lactate were determined with a YSI 2700 glu-
cose/lactate analyser (Yellow Springs Instruments, Yellow
Springs, OH). Ammonium was determined with an enzymatic
kit (Boehringer, Mannheim, Germany). Acetate, ethanol and
other possible metabolites present in the culture supernatant
were determined by 1H-NMR using a Jeol JNM ECP 400
spectrometer operating at 400 MHz (JEOL, Tokyo, Japan)
equipped with a JEOL stacman autosampler for 16 samples.
Culture supernatant was analyzed by adding 0.1 ml of D2O
containing 3-(trimethylsilyl) [D4]propionic acid sodium salt
(TMSP, 0.167 mM) to 0.9 ml sample. The water signal was
suppressed by irradiating the signal with standard NMR soft-
ware. The spectra were referenced using the TMSP signal at 0
ppm. Metabolite concentrations were quantified by integra-
tion of the relevant signals.
Protein
The amino-acid composition of biomass protein was deter-
mined after hydrolysis (6 M HCl, 24 h, 110°C) and subsequent
amino-acid analysis using an HPLC method as described pre-
viously [127]. Free amino acids in the culture supernatant
were determined using the same method. Cysteine and tryp-
tophan, which were destroyed during acid hydrolysis, were
calculated on the basis of the predicted amino-acid composi-
tion in the genome using ratios as described in Additional
data file 2. Glutamine and asparagine were converted to
glutamate and aspartate, respectively, during acid hydrolysis
and were also calculated on the basis of the predicted amino-
acid composition in the genome (see Additional data file 2).
Total biomass protein was calculated by summation of the
measured amino-acid concentrations and corrected for salt
present in the freeze-dried biomass. No correction was done
for amino acids present in peptidoglycan. The methods recov-
ery was determined as 0.85 ± 4%, based on measurements of
pure bovine serum albumin and corrections were made
accordingly. The measured amino-acid composition and the
assembly into protein can be found in Additional data file 2.
Fatty acids
The amount of total fatty acids and the fatty-acid composition
were analyzed using a modified gas chromatography method
[128]. Saponification reagent (1.2 ml of 3.75 M NaOH in 50/
50 v/v methanol/water) was added to 12 mg freeze-dried bio-
mass to liberate the fatty acid from cellular lipid. After vortex
mixing for 10 sec the samples were placed at 100°C for 30
min. After cooling for 15 min to room temperature, 2.4 ml of
methylation reagent (3.25 M HCl in methanol) was added and
after vortex mixing for 10 sec the samples were placed at 80°C
for 20 min. After cooling down to room temperature, the
fatty-acid methyl esters were extracted by adding 1.5 ml hex-
ane reagent (50/50 v/v hexane/methyl tertiary butyl ether).
Samples were mixed for 15 min and centrifuged (3 min, 1,834
g). The aqueous layer was removed and the organic phase was
washed by adding 3.0 ml washing agent (0.3 M NaOH). The
samples were mixed for 5 min and centrifuged again (3 min,
1,834 g). The organic phase was finally transferred to a gas
chromatograph vial and analyzed using a 6890 Agilent gas
chromatograph [129]. The standards and samples were
injected into the gas chromatograph equipped with a flame
ionization detector via an automated sequence run. An Agi-
lent 19091B-102 capillary column (Ultra 2; 5% Phe-methylsi-
loxane; 25 m × 0.200 mm; film thickness 0.33 μm) was used.
Oven temperature was programmed as follows: 60°C, hold 3
min; 280°C at 25°C/min, hold 4 min; 320°C at 15°C/min,
hold 2 min; 340°C at 20°C/min, hold 0 min). The injector
temperature was set at 275°C and detector temperature was
set at 375°C. Helium was used as carrier gas at a constant
flow-application of 2.0 ml/min. Fatty-acid methyl esters were
identified by their retention times in comparison to those of a
commercial standard (Microbial ID, Inc., Newark, DE, USA).
Calibration curves of pure fatty acids present in N. meningi-
tidis were made based on the identified fatty acids [128] and
confirmed in literature [130]. The pure fatty acids used as cal-
ibration standards were dissolved in dichloromethane
(Sigma, St Louis, MO). All fatty acids were purchased from
Sigma, except for palmitelaidic acid (C16:1-trans 9) which
was purchased from ICN Biomedicals (MP Biomedicals,
Irvine, CA). Hydroxy-fatty acids were quantified using C12:0-
2OH as an internal standard, whereas non-hydroxy-fatty
acids have been quantified using C15:0 as an internal stand-
ard. The measured fatty-acid concentrations were corrected
for salt present in the freeze-dried biomass. The measured
fatty-acid composition and the assembly into lipid can be
found in Additional data file 2.
Lipopolysaccharide
LPS was isolated by the hot phenol-water extraction as
described before [131]. Isolation and structural analysis of
lipid A was performed by nanoelectrospray tandem mass
spectrometry on a Finnigan LCQ in the positive ion mode as
described previously [132]. LPS was quantified on the basis of
the measured amount of C12:0-3OH (see Fatty acids).
RNA and DNA
The biomass RNA content was determined as described pre-
viously [133] and the biomass DNA content was determined
colorimetrically as described previously [134]. The DNA com-
position was derived from the complete nucleotide composi-http://genomebiology.com/2007/8/7/R136 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. R136.15
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tion in the genome sequence. For RNA the uridine content
was based on the thymine content in the genome sequence
[23]. The measured concentrations were corrected for salt
present in the freeze-dried biomass.The calculated RNA and
DNA composition and their assembly can be found in Addi-
tional data file 2.
Biomass composition
Biomass biosynthesis was set as a linear combination of the
macromolecules protein, DNA, RNA, lipid, peptidoglycan
and LPS, which were considerd to account for the overall bio-
mass composition. The energy requirement for biomass
assembly was also considered and estimated to be 13.27 mol
ATP/mol biomass. This value was calculated using linear
regression of available 1/Yx/ATP versus growth-rate data from
E. coli [122]. The accuracy of the estimation is, however, quite
low. A detailed calculation of the biomass composition and its
assembly, together with an overview of the metabolites meas-
ured in the culture supernatant and off-gas can be found in
Additional data file 2.
Modeling
Mathematical formulation
The genome-scale metabolic network was first simplified as
described in the text. Next, the stoichiometric matrix was
constructed from the set of reactions using a self-made com-
puter program running in Visual Basic (Microsoft, Seattle,
WA). Both Monte Carlo simulation and flux-balance analysis
were performed in self-made computer programs running in
Matlab (version 6.5 r13; Mathworks, Natick, MA).
Methods for solving a metabolic network or set of linear equa-
tions are discussed extensively elsewhere [135-138]. A brief
summary is given below. In steady-state growth, the reactions
of the considered metabolites form a set of linear equations
that can be expressed in matrix notation as:
where A (m × n) is the stoichiometric matrix which contains
m  metabolites and n  reactions, including (measured)
exchange reactions, and ν is the flux vector that contains the
unknown fluxes x and (measured) exchange rates r. A solu-
tion to the metabolic network will exist provided that A is
nonsingular. Singularities in A may arise due to reaction
dependence or network observability problems. Equation (1)
states a compound balance for each of the metabolites in the
system. If measurements are made of substrate and product
concentrations, and the conversion rates of these metabolites
are calculated, such a set of measured rates should match
Equation (1).
Error diagnosis and balancing
Methods for error diagnosis and balancing are discussed
extensively elsewhere [117,118]. A brief summary is given
here. To be able to do error diagnosis, the measurement set
should contain balanceable rates. Balanceable rates can be
found by calculating the redundancy matrix [117], which
contains linear relations between measured rates that are
thus balanceable. Parts of the relations are usually formed by
a carbon, nitrogen, and redox balance. In practice, all meas-
urements suffer from measurement noise, and sometimes
process noise, which leads to unavoidable inaccuracies in the
measured conversion rates. Consequently, the product of the
redundancy matrix and the measured rates is not zero, but
yields a vector of residuals, ε:
R·rm = ε (2)
where R is the redundancy matrix and and rm the measured
conversion rate vector.
To test whether ε can be explained from random measure-
ment errors, the following test function was developed [139]:
where he is the test function and ψε is the variance-covariance
matrix of the residual vector ε, which is calculated from the
variance-covariance matrix ψδ of the measurements accord-
ing to:
ψε = R·ψδ·RT (4)
when ε is due to random measurements only, he follows a χ2-
distribution with a number of degrees of freedom equal to the
rank of ψε [118]. When no gross errors are detected the meas-
ured rates should be balanced to obtain more reliable intrac-
ellular fluxes
rt = rm - δ (5)
where rt is the vector containing the balanced specific produc-
tion rates (mol/g/h) and δ is the vector containing the devia-
tions between measured and balanced rates, which can be
calculated using a weighed minimum last square approach
according to the following equation:
The resulting balanced measurement rate vector can be used
to calculate the unknown fluxes and production rates. As
described in more detail below, Monte Carlo simulation can
be used to determine the variance of a measured conversion
rate.
Network sensitivity analysis
The matrix containing the mass balances over the intracellu-
lar compounds can be checked for network sensitivity prob-
lems by performing singular value decomposition (SVD).
AA
x
r
⋅= ⋅
⎛
⎝
⎜
⎞
⎠
⎟ = ν 0 (1)
he
T =⋅ ⋅ − εψ ε ε
1 (3)
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SVD is a mathematical technique that decomposes matrix A
into three matrices as follows:
A = U·W·VT (7)
The matrix W is an orthogonal matrix containing the eigen-
values of the matrix. The columns of U, whose corresponding
elements of W are non-zero, form an orthonormal basis that
spans the range of A. The columns of V, whose corresponding
values of W are zero, are an othonormal basis for the
nullspace of A. In other words, the columns of V contain the
combination of fluxes and rates that cannot be uniquely iden-
tified. Here we use SVD to identify and isolate the combina-
tions of fluxes and unknown exchange rates that cannot be
uniquely identified (that is, calculated from the measure-
ments) [138]. It is worth noting that no measurements are
needed to perform this check. If underdetermined parts are
present, the number of solutions for the flux vector is infinite.
To reduce the number of allowable solutions for the underde-
termined parts of the metabolic network, limits on the range
of individual flux values can be set on the basis of available
biochemical and thermodynamic literature for the enzymatic
reactions. These constraints have the form:
α ≤ ν ≤ β (8)
where α and β are the lower and upper limits, respectively.
Thermodynamic constraints regarding the reversibility or
irreversibility of a reaction can be applied by setting α for the
corresponding flux to zero. To further shrink the original
solution space to a single solution, linear optimization can be
used to find the solution that optimizes a particular objective
function. Some examples of objective functions are those that
maximize biomass formation or minimize the production of
ATP, NADH, NADPH, or a particular metabolite [135,140].
An alternative objective function minimizes the sum of the
squares of the fluxes, and is called the minimum-norm con-
straint. The minimum-norm constraint minimizes the length
of the solution vector without any further restrictions using
the Moore-Penrose-pseudo-inverse of A [141]. The Moore-
Penrose-pseudo-inverse gives the one solution vector that has
the smallest Euclidian norm (for example, the smallest square
of its length). Like Bonarius [119], we hypothesize that the
minimum-norm constraint correctly assumes that the total
flux activity is minimized in order to fulfill the efforts of the
bacteria to achieve an efficient flux distribution.
Monte Carlo simulation
Error diagnosis and balancing are important aspects of flux-
balance analysis. Before error diagnosis can be done, errors in
the primary measurements need to be translated to errors
(that is, variances) in measured conversion rates. This can be
done using a Monte Carlo approach [115,116] as follows: The
various measured values and their standard deviations were
used as input to calculate the measured conversion rate of a
specific metabolite numerous times. The value of each meas-
ured variable in the mass balance equation of this specific
metabolite was simulated randomly within the allowed stand-
ard deviation interval of each variable. For example, the mass
balance describing the conversion rate of glucose contained
four measured variables: the glucose concentration in the
incoming and outgoing medium, the medium flow, and the
biomass concentration. In each Monte Carlo run, a random
value was assigned to each measured variable within the
allowed standard deviation interval of that variable. This was
done separately for all of the four measured variables. The
resulting four random values were used to calculate the con-
version rate of glucose. After numerous simulation runs, the
average glucose conversion rate and the corresponding vari-
ance was calculated from all the simulated conversion rates.
As stated in the text, accurate results were obtained after
10,000 simulations, resulting in an average measured con-
version rate with a normal error distribution (a prerequisite
for part of the flux-balance analysis procedure). All other
measured conversion rates were calculated similarly, result-
ing in a set of measured conversion rates and corresponding
variances that were subjected to error diagnosis.
In silico modeling
All in silico experiments were done using the simplified met-
abolic model. All simulations were performed in a self-made
computer programs running in Matlab (version 6.5 r13). The
flux through the non-growth-associated ATP-maintenance
reaction was fixed to 2.8 mmol/gram dry weight/h [122]. The
lower limit of irreversible reactions was set to zero and fluxes
through all other intracellular reactions had no upper or
lower limit. In addition, the production rate of all amino acids
and extracellular protein was set to zero. The following exter-
nal metabolites were allowed to freely enter and leave the sys-
tem: ammonia, water, phosphate, thiosulfate, sulfate, carbon
dioxide, oxygen, and protons. In addition, acetate, hydrogen
sulfide and ethanol were only allowed to leave the system.
Growth on different carbon sources was simulated by allow-
ing the cabon source under study to enter the system. The
consumption rate of all carbon sources was fixed to 4.23
mmol C/gram dry weight/h. In all simulations, the maximiza-
tion of biomass formation was used as an objective function.
Additional data files
The following additional data are available online with this
paper. Additional data file 1 is an Excel file that includes 7
worksheets. The first worksheet named 'genome-scale model'
includes the complete reaction database along with involved
genes, enzyme numbers and metabolites. The second work-
sheet named 'simplified model' contains the simplified meta-
bolic model. The third worksheet named 'abbreviations'
contains a list of abbreviations of the metabolites. The fourth
worksheet named 'redundancy matrix' contains the redun-
dancy matrices of the experimental data sets. The fifth work-http://genomebiology.com/2007/8/7/R136 Genome Biology 2007,     Volume 8, Issue 7, Article R136       Baart et al. R136.17
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sheet named 'measured rates, balanced rates' contains a table
in which the experimental set of measured rates and balanced
rates is given. In addition, the results of the statistical accept-
ance test are given in this table. The sixth worksheet named
'calculated fluxes' contains the calculated flux distributions of
both experimental data sets using the mimimum norm con-
straint. The seventh worksheet named 'in silico' contains the
flux distributions of the in silico experiments. Additional data
file 2 is a Word document that includes a detailed description
of the biomass composition together with an overview of the
metabolites measured in the culture supernatant and off-gas
and references [142-145].
Additional data file 1 A set of seven worksheets containing the information used to con- struct the model. The first worksheet named 'genome-scale model' includes the com- plete reaction database along with involved genes, enzyme num- bers and metabolites. The second worksheet named 'simplified  model' contains the simplified metabolic model. The third work- sheet named 'abbreviations' contains a list of abbreviations of the  metabolites. The fourth worksheet named 'redundancy matrix'  contains the redundancy matrices of the experimental data sets.  The fifth worksheet named 'measured rates, balanced rates' con- tains a table in which the experimental set of measured rates and  balanced rates is given. In addition, the results of the statistical  acceptance test are given in this table. The sixth worksheet named  'calculated fluxes' contains the calculated flux distributions of both  experimental data sets using the mimimum norm constraint. The  seventh worksheet named 'in silico' contains the flux distributions  of the in silico experiments. Click here for file Additional data file 2 A detailed description of the biomass composition and and over- view of the metabolites measure in the culture supernatant and off- gas. A detailed description of the biomass composition and and over- view of the metabolites measure in the culture supernatant and off- gas. Click here for file
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